induct
effect
cytotox
lymphocyt
ctl
andor
specif
antibodi
conserv
viral
protein
may
essenti
develop
safe
effect
sever
acut
respiratori
syndrom
coronaviru
sarscov
vaccin
dna
vaccin
repres
new
strategi
induct
humor
cellular
immun
respons
determin
abil
sarscov
nucleoprotein
n
protein
induc
antivir
immun
report
establish
stabl
line
express
sarscov
n
protein
use
target
specif
ctl
assay
also
express
recombin
n
protein
escherichia
coli
prepar
n
proteinspecif
polyclon
antibodi
mice
immun
n
proteinexpress
pcdnfn
vector
intramuscular
inject
found
dna
vaccin
induc
n
proteinspecif
antibodi
specif
ctl
activ
target
mice
immun
three
separ
inject
high
antibodi
titr
averag
titr
high
ctl
activ
e
e
e
observ
case
two
vaccin
inject
ctl
activ
also
high
e
e
e
howev
antibodi
titr
much
lower
averag
titr
result
suggest
sarscov
nucleocapsid
gene
might
candid
gene
sar
dna
vaccin
caus
agent
sever
acut
respiratori
syndrom
sar
identifi
new
type
coronaviru
sar
coronaviru
sarscov
determin
immunogen
viru
protein
possibl
vaccin
develop
import
sar
prevent
sarscov
genom
contain
five
major
open
read
frame
orf
encod
replicas
polyprotein
spike
envelop
e
membran
glycoprotein
nucleocapsid
protein
n
order
approxim
size
coronavirus
addit
sarscov
also
sever
small
nonstructur
orf
found
e
gene
n
gene
structur
protein
encod
five
orf
function
host
cell
entri
virion
morphogenesi
releas
virion
assembl
n
protein
bind
viral
rna
lead
format
helic
nucleocapsid
predict
n
protein
highli
charg
basic
protein
amino
acid
short
lysin
rich
region
suggest
nuclear
local
signal
vaccin
develop
critic
gener
protect
immun
respons
includ
specif
antibodi
cytotox
lymphocyt
ctl
gener
report
demonstr
protect
respons
elicit
antigen
virus
present
surfac
virion
n
protein
like
due
ctl
exampl
nucleoprotein
ebola
viru
measl
viru
lymphocyt
choriomening
viru
influenza
viru
may
induc
protect
ctl
porcin
coronaviru
transmiss
gastroenter
viru
tgev
n
protein
repres
antigen
tcell
respons
may
induc
cellular
humor
immun
respons
immunogen
sar
n
protein
especi
induct
specif
ctl
remain
unknown
recent
clinic
data
show
immunolog
respons
sar
patient
greatli
chang
infect
neutral
antibodi
product
lymphocyt
ratio
altern
etc
recent
wang
demonstr
n
protein
fragment
inhibit
bind
sarscov
lysat
serum
antibodi
sar
patient
bound
antibodi
sar
serum
base
observ
hypothes
n
protein
express
viral
infect
cell
may
potent
mediat
bodi
immun
system
thu
n
protein
may
potenti
target
sarscov
vaccin
address
issu
detect
n
proteinspecif
immun
respons
use
dna
vaccin
expect
found
dna
vaccin
n
protein
could
induc
specif
antibodi
specif
ctl
result
implic
sar
n
protein
may
target
dna
vaccin
femal
mice
week
purchas
shanghai
experiment
anim
center
shanghai
china
femal
adult
new
zealand
rabbit
kg
purchas
nanj
experiment
anim
center
nanj
china
myoblast
cell
line
deriv
mice
cell
line
cultur
dulbecco
modifi
eagl
medium
dmem
gibco
brl
supplement
mm
lglutamin
mm
hepe
gml
streptomycin
uml
penicillin
heatinactiv
fetal
bovin
serum
fb
gibco
brl
electropor
transfect
perform
exactli
describ
manufactur
manual
cell
porat
ii
gibco
brl
sarscov
nucleocapsid
protein
also
nucleoprotein
gene
n
gene
mention
follow
text
synthes
chemic
base
sequenc
report
genebank
atg
taa
end
full
code
region
ecori
bamhi
restrict
site
introduc
respect
subclon
result
plasmid
pgemfn
digest
ecori
bamhi
kb
releas
fragment
ligat
vector
digest
enzym
recombin
plasmid
pcdnfn
could
express
full
length
n
protein
mammalian
cell
use
dna
vaccin
vector
use
vaccin
control
express
recombin
sar
n
protein
es
cherichia
coli
polyclon
antibodi
prepar
use
pfu
dna
polymearas
chain
reaction
primer
pair
modifi
sar
n
gene
pgemfn
introduc
ndei
bamhi
site
end
end
respect
petfn
express
plasmid
made
ligat
ndeibamhi
n
gene
fragment
vector
digest
ndei
bamhi
make
express
plasmid
truncat
n
protein
petfn
cut
hindiii
bamhi
remov
region
aa
self
ligat
blunt
end
klenow
larg
fragment
result
plasmid
petpn
abl
express
truncat
n
protein
e
coli
construct
summar
fig
transform
petfn
petpn
recombin
induc
mm
iptg
h
cell
pellet
collect
centrifug
lyse
urea
ultrason
lysat
load
onto
column
preequilibr
tri
buffer
mm
trishcl
ph
mm
mm
edta
fraction
pass
collect
purif
protein
fraction
resolv
sdspage
gel
electrophoresi
recov
gel
kcl
stain
method
make
antin
protein
polyclon
antibodi
purifi
n
protein
mix
freund
adjuv
immun
sequenti
rabbit
three
four
time
sera
collect
week
final
immun
antibodi
titr
detect
enzymelink
immunosorb
assay
elisa
mice
bled
sera
assay
antibodi
activ
standard
quantit
elisa
briefli
g
purifi
protein
coat
well
elisa
plate
captur
reactiv
antibodi
serum
bind
igg
detect
hrplabel
secondari
antibodi
serum
pool
sever
nonimmun
mice
use
normal
serum
control
plasmid
dna
vaccin
prepar
qiagen
plasmid
purif
kit
purifi
dna
dissolv
sucros
concentr
mgml
femal
mice
immun
intramuscular
inject
ml
plasmid
dna
separ
site
side
quadricep
muscl
follow
one
two
booster
vaccin
week
interv
case
total
volum
l
inject
per
muscl
use
insulin
syring
g
needl
cytotox
assay
mice
splenocyt
harvest
week
two
three
inject
protocol
vitro
restimul
prime
splenocyt
achiev
cell
line
express
n
protein
made
transfect
pcdnfn
plasmid
cell
describ
section
singlecel
suspens
splenocyt
prepar
individu
mous
spleen
rpmi
medium
supplement
heatinactiv
fetal
bovin
serum
mm
lglutamin
iuml
interleukin
total
splenocyt
restimul
mitomycin
ctreat
target
cell
day
c
co
prior
ctl
assay
target
cell
treat
gml
mitomycin
c
h
wash
time
target
cell
wash
three
time
ad
triplic
rate
cell
per
well
roundbottom
plate
contain
differ
amount
restimul
effector
cell
effector
target
ratio
adjust
incub
c
co
h
ldh
activ
releas
supernat
determin
accord
method
publish
previous
maxim
ldh
releas
made
treat
cell
pb
contain
spontan
ldh
releas
determin
well
contain
target
cell
medium
percent
specif
lysi
calcul
follow
experiment
ldh
releas
spontan
ldh
releas
maximum
ldh
releas
spontan
ldh
releas
detect
sarsn
gene
express
target
cell
measur
n
proteinspecif
antibodi
produc
vaccin
mice
recombin
n
protein
polyclon
antibodi
prepar
first
full
length
truncat
n
gene
insert
express
vector
respect
induct
iptg
expect
petfn
petpn
cell
lysat
show
obviou
extra
express
band
kda
respect
shown
fig
b
also
found
protein
express
solubl
form
inclus
bodi
form
result
western
blot
assay
show
two
protein
could
also
react
serum
antibodi
mice
immun
pcdnfn
dna
vaccin
shown
fig
purifi
recombin
protein
absorpt
sdspage
gel
extract
method
result
pure
protein
inject
new
zealand
rabbit
polyclon
antibodi
prepar
two
kind
antibodi
fnab
antiful
length
n
protein
pnab
antiparti
n
protein
obtain
titrat
antibodi
averag
determin
express
pcdnfn
myoblast
cell
cell
tansfect
pcdnfn
plasmid
electropor
resist
stabl
line
screen
western
blot
assay
n
proteinexpress
stabl
clone
amplifi
target
cell
identif
initi
use
pnab
first
antibodi
detect
uniqu
band
size
kda
shown
fig
suggest
posttransl
modif
sarscov
nucleocapsid
gene
cell
mice
inject
intramuscularli
g
plasmid
dna
two
time
week
three
time
week
antin
protein
antibodi
measur
week
first
injec
tion
sera
collect
mice
inject
pcdnfn
construct
control
titer
quantifi
elisa
full
length
truncat
recombin
n
protein
shown
fig
antin
protein
antibodi
detect
mice
vaccin
pcdnfn
dna
mice
receiv
two
inject
specif
antibodi
level
much
lower
three
inject
antibodi
titr
also
calcul
defin
dilut
fold
nm
read
valu
three
time
control
serum
level
pn
result
show
antibodi
titr
two
inject
group
averag
group
receiv
three
inject
titr
averag
antin
protein
antibodi
rais
dna
vaccin
also
react
specif
recombin
n
protein
express
e
coli
shown
fig
examin
ctl
level
dnaimmun
mice
splenocyt
collect
individu
mice
week
two
three
inject
pcdnfn
splenocyt
cultur
restimul
vitro
day
mitomycin
ctreat
cell
cytolysi
activ
splenocyt
measur
ldh
releas
assay
mice
immun
three
inject
expect
group
vaccin
mice
receiv
pcdnfn
develop
much
higher
level
target
lytic
activ
e
e
e
case
two
inject
ctl
activ
also
high
level
e
e
e
shown
fig
left
part
right
upper
part
signific
differ
group
receiv
two
three
inject
ctl
activ
group
much
higher
control
shown
fig
right
lower
part
sarscov
vaccin
may
effect
method
prevent
sar
success
vaccin
abl
induc
proper
humor
andor
cellular
immun
respons
dna
vaccin
use
express
antigen
vivo
gener
humor
cellular
immun
respons
promis
therapi
especi
lifethreaten
diseas
report
detect
sarscov
n
proteinspecif
immun
respons
induc
dna
vaccin
found
specif
antibodi
titr
high
specif
ctl
activ
also
high
result
indic
n
protein
natur
exist
viru
particl
bind
viral
rna
abl
induc
strong
humor
cellular
immun
respons
induc
dna
vaccin
might
prospect
candid
gene
develop
sarscov
vaccin
prepar
paper
gao
et
al
publish
result
concern
sarsassoci
coronaviru
vaccin
monkey
use
adenoviralbas
vector
simultan
express
spike
protein
fragment
membran
protein
nucleocapsid
protein
vaccin
found
induc
sarscovspecif
tcell
viru
neutral
antibodi
respons
vitro
specif
ctl
activ
detect
paper
suggest
requir
nucleocapsid
protein
virusspecif
antibodi
gener
point
also
support
data
tgev
togeth
result
therefor
believ
sarscov
n
protein
import
enhanc
antibodi
product
also
specif
ctl
gener
n
protein
import
target
sar
vaccin
infect
sarscov
specif
antibodi
total
viru
n
protein
could
gener
antin
protein
antibodi
sar
patient
detect
week
onset
symptom
detect
almost
sar
patient
week
onset
diseas
believ
antibodi
respons
induc
n
protein
sar
immunodomin
may
play
import
role
viral
respons
result
studi
show
level
antibodi
gener
immun
two
inject
much
lower
three
inject
ctl
activ
alreadi
reach
high
level
thu
specul
cellular
immun
respons
might
also
play
import
role
immun
respons
sar
viral
infect
one
weak
studi
sar
anim
model
determin
protect
effect
fig
induct
sarscov
n
proteinspecif
ctl
mice
immun
pcdnfn
dna
splenocyt
mice
receiv
pcdnfn
vaccin
restimul
vitro
n
proteinexpress
cell
test
cytolyt
activ
ldhreleas
assay
cytolyt
activ
defin
specif
lysi
percentag
detect
variou
e
ratio
valu
experiment
point
repres
mean
triplic
repres
p
sar
viru
due
sever
restrict
acquir
sar
viru
studi
purpos
